Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon

References

• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506–13.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50–4.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793–8.
   PubMed Web of Science ®Google Scholar
• Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642–7.
   PubMedGoogle Scholar
• Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450–60.
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010;105:162–9.
   PubMed Web of Science ®Google Scholar
• Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14:40–6.
   PubMed Web of Science ®Google Scholar
• Sipponen T, Karkkainen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther 2008;28:1221–9.
   PubMed Web of Science ®Google Scholar
• Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008;40:547–53.
   PubMedGoogle Scholar
• Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362–6.
   PubMed Web of Science ®Google Scholar
• Berni CR, Rapacciuolo L, Romano MT, Tanturri de HL, Terrin G, Manguso F, Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis 2004;36:467–70.
   PubMedGoogle Scholar
• Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:524–34.
   PubMed Web of Science ®Google Scholar
• Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 2003;124:1728–37.
   PubMed Web of Science ®Google Scholar
• Husebye E, Ton H, Johne B. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am J Gastroenterol 2001;96:2683–7.
   PubMed Web of Science ®Google Scholar
• Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274–82.
   PubMed Web of Science ®Google Scholar
• Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615–21.
   PubMed Web of Science ®Google Scholar
• Ton H, Brandsnes O, Dale S, Holtlund J, Skuibina E, Schjonsby H, Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41–54.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7–27.
   PubMed Web of Science ®Google Scholar
• Bourreille A, Ignjatovic A, Aabakken L, Loftus Jr EV, Eliakim R, Pennazio M, Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009;41:618–37.
   PubMed Web of Science ®Google Scholar
• van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
   PubMed Web of Science ®Google Scholar
• Kirkwood BR, Sterne JAC. Essential medical statistics. Oxford: Blackwell Science Ltd; 2003.
   Google Scholar
• Rejchrt S, Bures J, Siroky M, Kopacova M, Slezak L, Langr F. A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy. Gastrointest Endosc 2004;59:651–4.
   PubMed Web of Science ®Google Scholar
• Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT, Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004;2:31–40.
   PubMed Web of Science ®Google Scholar